Speaker Biography
Dr Stephen Wright
R&D Director
GW Pharma Ltd.
Dr Wright joined GW’s senior management team in January 2004 as Research & Development Director and was promoted to the Board in March 2005.
Dr Wright has more than 15 years of experience in medicines development, having worked on both sides of the Atlantic, in large and small pharmaceutical companies. He joined GW from Ipsen, where he was Senior Vice President of Clinical Research & Development and a member of the UK Board of Directors. In this role he led teams responsible for regulatory success in both the US and EU.
Dr Wright has US drug development experience, firstly as Medical Director of Immunosciences, then Venture Head of Neuroscience at Abbott Laboratories, based near Chicago. He also spent some years at Glaxo in the UK as Associate Medical Director with special responsibility for sumatriptan and for the Glaxo range of topical steroids. His industry experience started when he joined Scotia Pharmaceuticals as Director of Immunology, Inflammation and Dermatology Research in 1988. He has experience across a range of therapeutic areas, but his particular expertise lies in the fields of neurology and oncology.
Dr. Wright has an MA in Social and Political Science from the University of Cambridge, where he also won a ‘Blue’ for representing the University at Cricket and Soccer. He qualified in Medicine (MB BS) at The Royal London Hospital. His other higher degrees include an MD, also from The University of Cambridge. He is a Fellow of the Royal College of Physicians of Edinburgh, and was elected to FFPM in 2000. His early medical career in the NHS culminated in him becoming Consultant Senior Lecturer at The Royal Free Hospital School of Medicine. He has authored more than 100 publications.